
کپسول های تاخیری و کپسول های دارای پوشش روده are related but not identical. “Delayed-release” is a broad pharmaceutical category for any design that postpones drug release, while “enteric-coated” refers specifically to a pH-sensitive polymer barrier. در عمل, all enteric-coated capsules are delayed-release, but delayed-release products can use other triggers (زمان, آنزیم ها, و غیره). Manufacturers can achieve delayed release by:
Each route has trade-offs in equipment, انعطاف پذیری, و پیچیدگی. به عنوان مثال, enteric-coated pellets allow multiple release phases in one capsule, but require precise pellet dosing on the دستگاه پرکن کپسول. Key production considerations include capsule shell compatibility (ژلاتین در مقابل HPMC), coating adhesion, and fill equipment settings. We compare each approach below to help you select the right strategy for your formulation.

"Delayed-release (DR)” is a general term for any oral dosage form engineered to hold its contents for a period after ingestion. به عبارت دیگر, آن را کنترل ها چه زمانی the drug is released. به عنوان مثال, an HPMC (هیدروکسی پروپیل متیل سلولز) capsule with an extra-thick wall may dissolve more slowly, delaying the release of its API. The goal is often to reduce stomach irritation or target delivery to a later point in the GI tract.
یک دارای پوشش روده ای (Acid-Resistant) capsule is one specific way to achieve delayed release. “Enteric” means intestine. These capsules are given a specialized polymer coating that is insoluble in stomach acid but soluble at higher pH (the small intestine). در عمل, the capsule stays intact in the stomach (pH ~ 1.5-3.5) and only dissolves when it reaches the small intestine (pH ~6.0–7.5). This precisely controls کجا the drug releases. پوشش های روده ای protect acid-labile drugs (به عنوان مثال. PPIs like omeprazole) and also protect the stomach lining from irritants (به عنوان مثال. آسپرین).
تمدید-انتشار (IS) کپسول: Forms that release drug slowly over an extended period (ساعت) to maintain steady blood levels. Not the same as delayed release. ER systems (hydrophilic matrices, پمپ های اسمزی, و غیره) control the rate of release from the moment of ingestion, rather than imposing an initial lag. به عنوان مثال, an ER capsule might gradually release drug over 8–24 hours. Delayed release simply imposes a delay, whereas extended release modulates release rate (یا هر دو).
به طور خلاصه, all enteric-coated capsules are delayed-release, but not all delayed-release capsules are enteric-coated. Delayed-release covers any mechanism (thicker shell, polymer matrix, مهره ها, و غیره) that shifts the release profile. Enteric-coated is the most common method, using pH-dependent coatings. Both ensure drugs aren’t released immediately, but delayed-release focuses on timing, while enteric-coated focuses on bypassing the stomach.

The table below summarizes the major differences between delayed-release and enteric-coated capsules:
| ویژگی | Delayed-Release Capsules | کپسول های پوشش دار انتریک |
| مکانیسم | زمان- or shell-thickness controlled delay; uses slower-dissolving shell (به عنوان مثال. HPMC) | pH-triggered polymer barrier; dissolves at intestinal pH |
| کنترل ها | چه زمانی release occurs (lag time) | کجا (in GI tract) release occurs |
| Acid Resistance | Depends on material; typically not specifically acid-resistant unless formulated that way | Engineered for gastric resistance; remains intact in stomach (pH<5.5) |
| Release Trigger | Intrinsic (mechanical/ time) or enzymatic factors | Alkaline pH (به عنوان مثال. pH ≥5.5–6.5) in small intestine |
| موارد استفاده / برنامه | General delayed effect, reduced GI side effects (به عنوان مثال. روغن ماهی, reflux-protecting NSAIDs, berberine) | Acid-sensitive APIs or intestine-targeted drugs (به عنوان مثال. PPI ها, pancreatic enzymes, مربوط به) |
| Typical Polymers/ Materials | HPMC یا پوسته ژلاتینی (thicker or crosslinked); fillers like starch, سلولز; timed-release beads (به عنوان مثال. اتیل سلولز) | Enteric polymers: فتالات استات سلولز (CAP), HPMC phthalate, Eudragit L/S (methacrylates), شلاک; نرم کننده ها (TEC, phthalates) |
| نمایه انتشار | Lag phase (often 30–60 min or longer) then rapid release | No release in acid; complete release after pH rise (often 2–4 hrs after dosing) |
| ثبات | Typically stable; moisture control if using HPMC (رطوبت کم) | Stability depends on polymer (some absorb moisture); enteric capsule shells may have low water content (4– 10%). Both need humidity control. |
| پیچیدگی تولید | Moderate – standard capsule filling, no coating step (if using HPMC shells) | Higher – extra steps (polymer mixing, spray coating or specialized shells) |
| هزینه | معتاد (standard capsule materials) | بالاتر (enteric polymers and processes add cost) |
| Regulatory/ Tests | Tested with standard dissolution (به عنوان مثال. USP 711) after lag time | Requires multi-stage testing: disintegration in pH 1.2 (no release), then dissolution at pH 6.8 (آزاد کردن) |
This table captures the core contrasts. Delayed-release “postpones” release based on material and thickness, while enteric capsules add a chemical barrier that only dissolves at intestinal pH. از نظر عملی, use delayed-release if the goal is زمان بندی (به عنوان مثال. reduce reflux or provide convenience) and use enteric-coated if the API is acid-sensitive or targeted to the intestines.

At a mechanistic level, delayed-release capsules often rely on the پوسته کپسول itself and fillers:
The science: gastric pH (~1–3) keeps the film intact (no release), but once the capsule passes to the small intestine (pH ~6–7), the enteric film swells and dissolves, liberating the drug. به عنوان مثال, omeprazole is formulated as a delayed-release capsule با پوشش روده; without the coating it would be destroyed by stomach acid.
خلاصه, delayed-release encapsulates the broad concept (“hold the drug back”), whereas enteric coating is the technology to achieve that for stomach-sensitive cases.
Delayed-Release Capsule Examples: Delayed-release capsules are often used for ingredients that benefit from a lag but are not damaged by acid. نمونه های رایج عبارتند از روغن های امگا 3 or certain botanicals which can cause reflux if released immediately. Some probiotics (acid-tolerant strains) or peptides fall here if you only need to reduce dose frequency or stomach upset. اساسا, if the API irritates the stomach (like an NSAID) but isn’t itself acid-sensitive, delayed-release can improve tolerance.
Enteric-Coated Capsule Examples: Enteric-coated capsules are chosen for acid-labile drugs and targeted GI delivery. Classic examples: مهارکننده های پمپ پروتون (امپرازول, esomeprazole) and other stomach-acid-sensitive drugs, digestive enzymes (به عنوان مثال. pancrelipase for cystic fibrosis), و پروبیوتیک ها (so the bacteria survive to the gut). They’re also used for vitamins/herbals when needed (به عنوان مثال. SAMe supplements) and some rectally-targeted medications. Many OTC aspirin or ibuprofen products have “enteric-coated” versions to protect the stomach lining. کلید این است: if your API or ingredient is inactivated or irritating in acid, enteric is the way to go.

Pharmaceutical manufacturers have several routes to create a delayed-release capsule. Below is an overview of four common approaches, from most to least traditional. Each route has a different process flow, equipment need, و انعطاف پذیری:

شکل: Four main routes to achieve delayed-release capsules. مسیر 1 coats the filled capsule; مسیر 2 uses a ready-to-fill enteric shell; مسیر 3 fills with enteric-coated pellets; مسیر 4 (not shown) is a combination of pellets with other formats.
Each route requires appropriate downstream steps. به عنوان مثال, all routes above except Route 2 include a standard capsule locking/finishing step. Routes 1 و 3 both include a dedicated enteric-coating operation (on capsules or pellets). مسیر 2 may use a simple sealing machine if special shells come pre-gelled. See the Mermaid chart for flows.
Each piece of equipment must be validated for uniformity. High-shear spray nozzles and precise temperature/humidity control are critical to avoid defects (به عنوان مثال. “orange peel” surface, ترک خوردن).
QC is crucial for both capsule types. تست های کلیدی شامل:
According to Kolmar’s overview, “rigorous testing is conducted to ensure each batch meets industry standards for content uniformity, انحلال, and stability”. در عمل, especially for enteric-coated forms, the combined disintegration/dissolution test is paramount.
When scaling production from lab to commercial batches:
Common problems (especially with enteric coatings) شامل شود:
به طور کلی, start by examining in-process moisture (too high makes coatings sticky), spray droplet size, and batch-to-batch consistency of excipients. زیاد coating defects can be prevented with careful validation and controls.
To decide which is right for your product, در نظر گرفتن:
A quick چک لیست:
Choosing early in development is critical. Using the wrong capsule can ruin stability or dissolution and be costly to fix later. Work closely with formulation experts and equipment engineers to make the right call.
خلاصه, انتشار با تاخیر is a broad strategy (any way to postpone release), در حالی که کپسول های دارای پوشش روده are one specific method (acid-resistant film). To design the right delayed-release capsule, first define your release target (به عنوان مثال. intestinal absorption, محافظت از معده) and practical constraints (existing equipment, formulation properties). Then pick a route: coat the filled capsule, use a pH-sensitive shell, fill with coated pellets, or a hybrid approach. Each route will affect your capsule filling process: به عنوان مثال. pellet fills need pellet-dosing modules, enteric shells require sourcing special capsules, and coated capsules require post-fill coating.
No matter which path you take, remember to test rigorously. Dissolution in acid and buffer, fill-weight uniformity, pellet integrity, and stability are critical checkpoints. دستگاه های پرکن کپسول مدرن (like JinLu’s automatic capsule fillers) are quite versatile and can handle either route. They support powders, granules and pellets in hard capsules, making implementation feasible on the production floor.
If you’re evaluating delayed-release options for your product, we encourage you to send us your formulation details (اندازه کپسول, مواد, نوع پر کردن, target dose, و غیره). Our engineering team can then advise which approach fits best and offer sample tests on our equipment. Use the information above to frame your questions, and let us help you choose the safest, most cost-effective manufacturing route for your delayed-release capsules.
نه دقیقا. “Delayed-release” is a general term meaning the drug isn’t released immediately after swallowing. Enteric-coated capsules are one common way to achieve delayed release (by using an acid-resistant coating). So all enteric-coated capsules are delayed-release forms, but delayed-release could also include time-release systems or special multiparticulate designs.
Plain gelatin or standard HPMC capsules dissolve in the stomach and provide immediate release (HPMC may dissolve a bit slower, but still in acid). They have no inherent delay. To achieve delayed release, you need either an enteric coating on the capsule or fill (shell polymers or pellets) that resist acid. به عنوان مثال, Capsugel’s Vcaps® Enteric (HPMC with added polymers) are specially manufactured shells that confer acidity resistance.
Manufacturers can use several routes. They may apply an enteric coating to a filled capsule, use a ready-to-fill functional capsule shell, fill a standard capsule with enteric-coated pellets or granules, or combine coated pellets, مینی تبلت ها, and other fill materials. The best route depends on the required release profile and production setup.
بله. Hard gelatin capsules can be coated with suitable enteric polymers, but the coating formulation and process conditions must be optimized for adhesion, یکپارچگی کپسول, رطوبت, خشک شدن, and the cap-body joint. The finished product should then be tested to confirm that the required delayed-release or gastro-resistant performance is achieved.
بله. Filling enteric-coated pellets or granules into standard gelatin or HPMC capsules is a widely used approach for delayed or gastro-resistant drug delivery. در تولید, manufacturers need to control pellet flow, دقت دوز, mechanical handling, and coating damage because excessive abrasion can affect the intended release profile.
معمولا بله, but compatibility depends on the capsule shell, مواد را پر کنید, ویژگی های ذرات, دوز, و سرعت تولید. An automatic capsule filling machine may require different dosing configurations for powder, گرانول ها, گلوله ها, یا تبلت های کوچک. Pellet-filled products also need gentle handling and accurate dosing to protect the functional coating.
Testing normally evaluates whether the dosage form resists the required acidic stage and then releases the drug appropriately under the specified later-stage conditions. Manufacturers may also assess dissolution, تجزیه, coating integrity, fill-weight consistency, آسیب گلوله, و ثبات. The exact acceptance criteria should follow the applicable product specification, pharmacopoeial method, و الزامات نظارتی.
Both can become brittle if too dry. Gelatin shells usually have higher moisture, giving them a bit more flexibility (unless exposed to extreme dry conditions). HPMC shells tend to be drier and can crack if mishandled. Monitor humidity during storage and filling. به طور کلی, handle HPMC shells more gently and consider humidifying capsules slightly before filling if brittleness is a concern. Ensure filling machines run under controlled climate (some lines use humidifiers to protect HPMC shells).
Manufacturers should consider capsule size and material, powder or pellet fill type, دقت دوز, pellet handling, capsule separation and locking, ظرفیت تولید, changeover requirements, تمیز کردن, و پشتیبانی اعتبار سنجی. For pellet-based delayed-release products, the filling system should be able to dose the pellets consistently without damaging their functional coating.
There are several common approaches: coating the filled capsule with an enteric polymer, using a ready-to-fill enteric-resistant capsule shell, filling standard capsules with enteric-coated pellets or granules, and combining immediate- and delayed-release components in one capsule. The best route depends on the formulation, تجهیزات, release target, و الزامات تولید.
مراجع:
1.Oral Gastro-resistant Formulations – State of the Art, Advances and Prospects: A Review —— Springer Nature
2.Fish Oil Containing Omega-3 Acids Delayed-Release Capsules —— USP
3.ارزیابی در شرایط آزمایشگاهی کپسول های HPMC پوشش داده شده با روده - تأثیر عوامل فرمولاسیون بر عملکرد محصول —— PMC
4.Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules —— PMC
5.Enteric coated HPMC capsules designed to achieve intestinal targeting —— PMC
6.Guidance for Industry SUPAC-MR: Modified Release Solid Oral Dosage Forms —— ایالات متحده. سازمان غذا و داروی
مد کوچک, بنیانگذار Jinlupacking, به ارمغان می آورد 20 سالها تخصص در بخش ماشین آلات دارویی. تحت رهبری او, جینلو تبدیل به یک تامین کننده قابل اعتماد با طراحی یکپارچه شده است, تولید, و فروش. پتی مشتاق به اشتراک گذاری دانش عمیق خود در صنعت است تا به مشتریان کمک کند تا پیچیدگی های بسته بندی دارو را طی کنند., اطمینان حاصل شود که آنها نه تنها تجهیزات را دریافت می کنند, اما یک مشارکت خدمات یک مرحله ای واقعی متناسب با اهداف تولید آنها.